Apatinib plus vinorelbine: A novel combination of all-oral regimen in heavily pretreated patients with metastatic HER2-negative breast cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e13096
Abstract: e13096Background: Antiangiogenic therapy in combination with chemotherapy is effective in control advanced breast cancer. Apatinib is an oral highly potent tyrosine kinase inhibitor targeting vascu... read more here.
Keywords: combination; apatinib plus; cancer apatinib; breast cancer ... See more keywords